Traduction de «patients with stable coronary artery disease » (Français → Néerlandais) :

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-bl Lancet 362 : 782-788(2003)
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-bli Lancet 362 : 782-788(2003)

J. Hypertension 21, 1771- 1773 (2003) The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators.
J. Hypertension 21, 1771-1773 (2003) The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators.

Lancet 362, 782-788 (2003) H.D. White: Should all patients with coronary disease receive angiotensin-convertingenzyme inhibitors?
Lancet 362, 782-788 (2003) H.D. White: Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?

Hirsch AT, Haskal ZJ, Hertzer NR et al. ACC/AHA 2005 Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric and abdominal aortic): Executive summary.
2011: Rooke TW, Hirsch AT, Misra S et al. 2011 ACCF/AHA Focused update of the guideline for the management of patients with peripheral artery disease.

Update 2011: Rooke TW, Hirsch AT, Misra S et al. 2011 ACCF/AHA Focused update of the guideline for the management of patients with peripheral artery disease.
Scottish Intercollegiate Guidelines Network. Diagnosis and management of peripheral arterial disease.

36. McKevitt FM, Macdonald S, Venables GS, Cleveland TJ, Gaines PA. Complications following carotid angioplasty and carotid stenting in patients with symptomatic carotid artery disease.
following carotid angioplasty and carotid stenting in patients with symptomatic carotid artery disease.

Cacoub PP, Bhatt DL, Steg PG, Topol EJ, Creager MA. Patients with peripheral arterial disease in the CHARISMA trial.
Warfarin Antiplatelet Vascular Evaluation Trial Investigators, Anand S, Yusuf S et al. Oral anticoagulant and antiplatelet tjerapy and peripheral arterial disease.